发明人唐晓军,朱建伟,孙丽萍. "Method for the Synthesis of 50411-91-1
CTK4J2581
S-[2-[3-[[4-[[[(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-4-HYDROXY-3-PHOSPHONOOXYOXOLAN-2-YL]METHOXY-HYDROXYPHOSPHORYL]OXY-HYDROXYPHOSPHORYL]OXY-2-HYDROXY-3,3-DIMETHYLBUTANOYL]AMINO]PROPANOYLAMINO]ETHYL] 3-OXODECANETHIOATE" [P]. 中国发明专利, 专利号 CN 115723084 B, 授权公告日 2022-05-06.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of 10:0(3-氧代)辅酶A in Pharmaceutical Formulations". Chromatographia, 2010, 898, (7), 7500-7508.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of 10:0(3-氧代)辅酶A as an Impurity". Environ. Sci. Technol., 2018, 1256, 4860-4878.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of 50411-91-1
CTK4J2581
S-[2-[3-[[4-[[[(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-4-HYDROXY-3-PHOSPHONOOXYOXOLAN-2-YL]METHOXY-HYDROXYPHOSPHORYL]OXY-HYDROXYPHOSPHORYL]OXY-2-HYDROXY-3,3-DIMETHYLBUTANOYL]AMINO]PROPANOYLAMINO]ETHYL] 3-OXODECANETHIOATE Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2014, 1599, 1071-1092.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate 10:0(3-氧代)辅酶A Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2021, 1323, (11), 5472-5479.